Literature DB >> 4625047

Tumor angiogenesis.

A I Holleb, J Folkman.   

Abstract

Mesh：

Year:  1972        PMID： 4625047     DOI： 10.3322/canjclin.22.4.226

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


× No keyword cloud information.
  12 in total

1.  The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40.

Authors:  Harry D Bear; Gong Tang; Priya Rastogi; Charles E Geyer; Christine K Zoon; Kelley M Kidwell; André Robidoux; Luis Baez-Diaz; Adam M Brufsky; Rita S Mehta; Louis Fehrenbacher; James A Young; Francis M Senecal; Rakesh Gaur; Richard G Margolese; Paul T Adams; Howard M Gross; Joseph P Costantino; Soonmyung Paik; Sandra M Swain; Eleftherios P Mamounas; Norman Wolmark
Journal:  Ann Surg Oncol       Date:  2016-11-18       Impact factor: 5.344

2.  Firefly luciferase-based dynamic bioluminescence imaging: a noninvasive technique to assess tumor angiogenesis.

Authors:  Amy Sun; Lewis Hou; Tiffany Prugpichailers; Jason Dunkel; Maziyar A Kalani; Xiaoyuan Chen; M Yashar S Kalani; Victor Tse
Journal:  Neurosurgery       Date:  2010-04       Impact factor: 4.654

Review 3.  New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer.

Authors:  Huiping Qiang; Qing Chang; Jianlin Xu; Jialin Qian; Yanwei Zhang; Yuqiong Lei; Baohui Han; Tianqing Chu
Journal:  J Cancer Res Clin Oncol       Date:  2020-02-17       Impact factor: 4.553

Review 4.  Hijacking the vasculature in ccRCC--co-option, remodelling and angiogenesis.

Authors:  Chao-Nan Qian
Journal:  Nat Rev Urol       Date:  2013-03-05       Impact factor: 14.432

Review 5.  Dormancy in solid tumors: implications for prostate cancer.

Authors:  Nazanin S Ruppender; Colm Morrissey; Paul H Lange; Robert L Vessella
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

6.  AAV2-mediated in vivo immune gene therapy of solid tumours.

Authors:  Sara A Collins; Alexandra Buhles; Martina F Scallan; Patrick T Harrison; Deirdre M O'Hanlon; Gerald C O'Sullivan; Mark Tangney
Journal:  Genet Vaccines Ther       Date:  2010-12-20

7.  Anticancer activity of TTAC-0001, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) monoclonal antibody, is associated with inhibition of tumor angiogenesis.

Authors:  Dong Geon Kim; Younggeon Jin; Juyoun Jin; Heekyoung Yang; Kyeung Min Joo; Weon Sup Lee; Sang Ryeol Shim; Sung-Woo Kim; Jinsang Yoo; Sang Hoon Lee; Jin-San Yoo; Do-Hyun Nam
Journal:  MAbs       Date:  2015-09-01       Impact factor: 5.857

8.  A comparison of CD105 and CD31 expression in tumor vessels of hepatocellular carcinoma by tissue microarray and flow cytometry.

Authors:  Hongyan Qian; Liping Yang; Wenjing Zhao; Haizhen Chen; Song He
Journal:  Exp Ther Med       Date:  2018-08-01       Impact factor: 2.447

9.  CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer.

Authors:  Chun Chen; Zhuo-Qing Xu; Ya-Ping Zong; Bao-Chi Ou; Xiao-Hui Shen; Hao Feng; Min-Hua Zheng; Jing-Kun Zhao; Ai-Guo Lu
Journal:  Cell Death Dis       Date:  2019-02-21       Impact factor: 8.469

Review 10.  Angiogenesis in NSCLC: is vessel co-option the trunk that sustains the branches?

Authors:  Ana Luísa Coelho; Mónica Patrícia Gomes; Raquel Jorge Catarino; Christian Rolfo; Agostinho Marques Lopes; Rui Manuel Medeiros; António Manuel Araújo
Journal:  Oncotarget       Date:  2017-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.